optiscan successful at ddw

Excerpts from annoucement to ASX:
DDW is the largest and most prestigious international meeting for Gastroenterologists. Up to 25,000 gastro doctors attend each year to keep themselves abreast of the latest advances in GI medicine.
Overnight Australian time, over 125 invitees attended a Pentax hosted special symposium on endo-microscopy at the Digestive Diseases Week Congress, Los Angeles.
A distinguished panel of nine leading doctors from USA, Europe and Asia made presentations on clinical applications of endo-microscopes.
“This DDW symposium has been an outstanding success.” said Mr David Woods, President of Pentax of America Corporation. "I am confident this event will accelerate sales of ISC 1000 endo-microscope systems.”

Background on Optiscan :
Optiscan is a global leader in microscopic imaging technologies for medical markets.
Optiscan’s unique and patented technologies enable high-powered microscopes to be miniaturised and used inside the body. The technology enables microscopic imaging of up to 1000 times magnification to be achieved. Doctors can use the technology to instantly see cellular level details of tissue without the requirement to surgically remove tissue (biopsy).